Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis

Source link : https://www.newshealth.biz/health-news/oral-il-23-inhibitor-calms-moderate-to-severe-psoriasis/

Among 255 patients with plaque psoriasis randomly assigned to receive either placebo or an oral interleukin (IL)–23 receptor antagonist peptide dubbed JNJ-77242113 (Janssen), 79% of those who were assigned to the oral agent at the highest dose of 100 mg twice daily had a reduction in the Psoriasis Area and Severity Index (PASI) score at […]

Author : News Health

Publish date : 2024-02-07 22:09:57

Copyright for syndicated content belongs to the linked Source.